scispace - formally typeset
S

Sho Yoshida

Researcher at Chiba University

Publications -  344
Citations -  7231

Sho Yoshida is an academic researcher from Chiba University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 42, co-authored 305 publications receiving 7032 citations. Previous affiliations of Sho Yoshida include Toho University.

Papers
More filters
Journal ArticleDOI

CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.

TL;DR: Results provide direct evidence that CD4+ but not CD8+ T-cells mediate antigen-induced eosinophil recruitment in the airways and that IL-5 mediates this eos inophil recruited in the trachea.
Journal ArticleDOI

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.

TL;DR: Results suggest that T cells with invariant V alpha 24J alpha Q TCR would function as regulatory T cells, whereas T cells bearing other invariantV alpha 24 TCR in SSc patients could be autoaggressive T cells in nature.
Journal ArticleDOI

Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue.

TL;DR: It is indicated that VCAM-1/VLA-4 interaction plays a predominant role in controlling antigen-induced eosinophil and T cell recruitment into the tissue and that the induction of VCam-1 expression on the endothelium at the site of allergic inflammation regulates this eos inophils and Tcell recruitment.
Journal ArticleDOI

Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells.

TL;DR: Results indicate that IFN-gamma regulates antigen-induced eosinophil recruitment into the tissue by inhibiting CD4+ T cell infiltration.
Journal ArticleDOI

Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen

TL;DR: The results suggest that AFI measured by ultrasonography may be a new indicator of visceral fat deposition, and may reflect metabolic disorders such as lipid metabolism and glucose metabolism disorders.